Wespran

Wespran is developing Freed biotech to capture and convert industrial CO₂ emissions into valuable resources like green methanol. Combining physics, biochemistry, and bioinformatics, we use engineered enzymes to provide a turnkey onsite service—without hydrogen. This transforms decarbonization from a regulatory burden into a profitable opportunity for heavy industries. Backed by Silicon Valley biotech VC General Inception and partnering with France’s National Center for Scientific Research (CNRS), we are seeking: - Seed investment to accelerate R&D and commercialization - Industrial partners to deploy our pilot - R&D collaborations to further optimize our process We are open to discussions with investors, industry leaders, and research partners.